Expression of human apolipoprotein Al in ApoE-/- mice reduces both atherosclerotic lesions and markers of inflammation

被引:0
|
作者
Zaiss, A. K.
Li, M.
Muruve, D. A.
Chan, L. B.
Wong, N. C.
机构
[1] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB T2N 1N4, Canada
[2] Univ Calgary, Dept Med, Calgary, AB T2N 1N4, Canada
[3] Baylor Coll Med, Endocrinol Sect, Dept Med, Houston, TX 77030 USA
关键词
D O I
10.1016/S1567-5688(06)80353-3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:94 / 94
页数:1
相关论文
共 50 条
  • [21] Caffeic acid protects against atherosclerotic lesions and cognitive decline in ApoE-/- mice
    Sun, Rui
    Wu, Tao
    Xing, Shu
    Wei, Sheng
    Bielicki, John K.
    Pan, Xuefang
    Zhou, Mingyang
    Chen, Jianbin
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2023, 151 (02) : 110 - 118
  • [22] CD40 Targeted Imaging of Atherosclerotic Plaque Lesions in ApoE-/- Mice
    Grafe, Michael
    Dietrich, Thore
    Stibenz, Dietger
    Klohs, Jan
    Wunder, Andreas
    Lutgens, Esther
    Daemen, Mat
    Fleck, Eckart
    Graf, Kristof
    CIRCULATION, 2008, 118 (18) : S554 - S554
  • [23] Unstable atherosclerotic lesions in ApoE-/- mice with increased circulating levels of Ang II
    Mazzolai, L
    Korber, M
    Bouzourene, K
    Aubert, JF
    Gabbiani, G
    Nussberger, J
    Hayoz, D
    HYPERTENSION, 2003, 42 (04) : 632 - 632
  • [24] Orthopedic surgery increases atherosclerotic lesions and necrotic core area in ApoE-/- mice
    Fuijkschot, Wessel W.
    Morrison, Martine C.
    van der Linden, Rianne
    Krijnen, Paul A. J.
    Zethof, Ilse P. A.
    Theyse, Lars F. H.
    Kleemann, Robert
    Niessen, Hans W. M.
    Smulders, Yvo M.
    ATHEROSCLEROSIS, 2016, 255 : 164 - 170
  • [25] Endothelial NADPH oxidase 4 protects ApoE-/- mice from atherosclerotic lesions
    Craige, Siobhan M.
    Kant, Shashi
    Reif, Michaella
    Chen, Kai
    Pei, Yongmei
    Angoff, Rebecca
    Sugamura, Koichi
    Fitzgibbons, Timothy
    Keaney, John F., Jr.
    FREE RADICAL BIOLOGY AND MEDICINE, 2015, 89 : 1 - 7
  • [26] Atherosclerotic lesions development is not prevented in the GPIbbeta-/-ApoE-/- double knockout mice
    Strassel, C.
    Hechler, B.
    Bull, A.
    Freund, M.
    Cazenave, J.
    Gachet, C.
    Lanza, F.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 183 - 183
  • [27] Expression of miRNA-155 in carotid atherosclerotic plaques of apolipoprotein E knockout (ApoE-/-) mice and the interventional effect of rapamycin
    Ma, Juanjuan
    Yang, Shaonan
    Ma, Aijun
    Pan, Xudong
    Wang, Hongliang
    Li, Na
    Liu, Shihai
    Wu, Mei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2017, 46 : 70 - 74
  • [28] Expression of ryanodine receptor 3 during the atherosclerotic plaque formation of apolipoprotein E gene-deficient (ApoE-/-) mice
    Zheng, Ye
    Li, Yongxing
    Zhao, Lei
    Qi, Xiangqian
    Yu, Jing
    Han, Jia
    Yan, Liqiu
    Cao, Xufen
    Li, Zhe
    Guo, Nan
    Lian, Zheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (02): : 1038 - 1045
  • [29] FORMONONETIN, A CLA1 UPREGULATOR, REDUCES ATHEROSCLEROTIC LESION FORMATION IN APOE-/- MICE
    Xu, Y.
    Liu, Q.
    Zhao, P.
    Li, N.
    Lai, F.
    Xu, Y.
    He, X.
    Jiang, W.
    Hong, B.
    Si, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 150 - 150
  • [30] Liver X receptor agonist T0901317 reduces atherosclerotic lesions in apoE-/- mice by up-regulating NPC1 expression
    Ou Xiang
    Dai XiaoYan
    Long ZhiFeng
    Tang YaLing
    Cao DongLi
    Hao XinRui
    Hu YanWei
    Li XiaoXu
    Tang ChaoKe
    SCIENCE IN CHINA SERIES C-LIFE SCIENCES, 2008, 51 (05): : 418 - 429